Anixa Biosciences, Inc. (ANIX)
2.87
+0.02
(+0.70%)
USD |
NASDAQ |
Apr 14, 16:00
2.87
0.00 (0.00%)
After-Hours: 19:45
Anixa Biosciences EPS Diluted (Quarterly) : -0.0772 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -4.413 |
| Kyntra Bio, Inc. | -3.611 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.585M |
| Total Expenses (Quarterly) | 2.565M |
| Enterprise Value | 80.31M |
| Earnings Yield | -10.97% |
| Normalized Earnings Yield | -10.98 |